chief executive officer

Patient nonadherence to medication is a well-known problem plaguing health care. For this reason, many quality measures now focus on improving adherence.

The move away from traditional quantity-driven models toward value-based care has helped put pharmacists at the forefront of efforts to improve the quality of care patients receive.

Health care reform has both good and bad news for patients. Americans will receive health care coverage and seniors no longer have to worry about falling into the Medicare "doughnut hole," but affordable biogenerics will not be available for decades.

Although questions have been raised regarding the safety and efficacy of generic drugs, compared with their brand drug counterparts, the FDA supports the bioequivalence of generic drugs and is helping to deliver important information to patients.

With nearly 40 million Americans not filling a prescription in 2008, according to IMS Health, affordable generics are even more important in this economic climate.